The ICCAM platform study: An experimental medicine platform for evaluating new drugs for relapse prevention in addiction. Part B: fMRI description

John McGonigle, Anna Murphy, Louise Paterson, Laurence Reed, Liam J. Nestor, Jonathan Nash, Rebecca Elliott, Karen D. Ersche, Remy Flechais, Rexford Newbould, Csaba Orban, Dana Smith, Eleanor Taylor, Adam D. Waldman, Trevor W. Robbins, J. F. William Deakin, David J. Nutt, Anne Lingford-Hughes, John Suckling

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Objectives:
We aimed to set up a robust multi-centre clinical fMRI and neuropsychological platform to investigate the neuropharmacology of brain processes relevant to addiction – reward, impulsivity and emotional reactivity. Here we provide an overview of the fMRI battery, carried out across three centres, characterizing neuronal response to the tasks, along with exploring inter-centre differences in healthy participants.

Experimental design:
Three fMRI tasks were used: monetary incentive delay to probe reward sensitivity, go/no-go to probe impulsivity and an evocative images task to probe emotional reactivity. A coordinate-based activation likelihood estimation (ALE) meta-analysis was carried out for the reward and impulsivity tasks to help establish region of interest (ROI) placement. A group of healthy participants was recruited from across three centres (total n=43) to investigate inter-centre differences.

Principle observations:
The pattern of response observed for each of the three tasks was consistent with previous studies using similar paradigms. At the whole brain level, significant differences were not observed between centres for any task.

Conclusions:
In developing this platform we successfully integrated neuroimaging data from three centres, adapted validated tasks and applied whole brain and ROI approaches to explore and demonstrate their consistency across centres.
LanguageEnglish
Pages3-16
Number of pages14
JournalJournal of Psychopharmacology
Volume31
Issue number1
Early online date4 Oct 2016
DOIs
Publication statusPublished - 1 Jan 2017
Externally publishedYes

Fingerprint

Impulsive Behavior
Secondary Prevention
Reward
Biomedical Research
Magnetic Resonance Imaging
Healthy Volunteers
Brain
Neuropharmacology
Pharmaceutical Preparations
Neuroimaging
Meta-Analysis
Motivation
Research Design

Cite this

McGonigle, John ; Murphy, Anna ; Paterson, Louise ; Reed, Laurence ; Nestor, Liam J. ; Nash, Jonathan ; Elliott, Rebecca ; Ersche, Karen D. ; Flechais, Remy ; Newbould, Rexford ; Orban, Csaba ; Smith, Dana ; Taylor, Eleanor ; Waldman, Adam D. ; Robbins, Trevor W. ; Deakin, J. F. William ; Nutt, David J. ; Lingford-Hughes, Anne ; Suckling, John. / The ICCAM platform study : An experimental medicine platform for evaluating new drugs for relapse prevention in addiction. Part B: fMRI description. In: Journal of Psychopharmacology. 2017 ; Vol. 31, No. 1. pp. 3-16.
@article{56c9c07e5eeb4c6697a8965f35a8d9b5,
title = "The ICCAM platform study: An experimental medicine platform for evaluating new drugs for relapse prevention in addiction. Part B: fMRI description",
abstract = "Objectives:We aimed to set up a robust multi-centre clinical fMRI and neuropsychological platform to investigate the neuropharmacology of brain processes relevant to addiction – reward, impulsivity and emotional reactivity. Here we provide an overview of the fMRI battery, carried out across three centres, characterizing neuronal response to the tasks, along with exploring inter-centre differences in healthy participants.Experimental design:Three fMRI tasks were used: monetary incentive delay to probe reward sensitivity, go/no-go to probe impulsivity and an evocative images task to probe emotional reactivity. A coordinate-based activation likelihood estimation (ALE) meta-analysis was carried out for the reward and impulsivity tasks to help establish region of interest (ROI) placement. A group of healthy participants was recruited from across three centres (total n=43) to investigate inter-centre differences.Principle observations:The pattern of response observed for each of the three tasks was consistent with previous studies using similar paradigms. At the whole brain level, significant differences were not observed between centres for any task.Conclusions:In developing this platform we successfully integrated neuroimaging data from three centres, adapted validated tasks and applied whole brain and ROI approaches to explore and demonstrate their consistency across centres.",
keywords = "brain, human, magnetic resonance imaging, substance-related disorders",
author = "John McGonigle and Anna Murphy and Louise Paterson and Laurence Reed and Nestor, {Liam J.} and Jonathan Nash and Rebecca Elliott and Ersche, {Karen D.} and Remy Flechais and Rexford Newbould and Csaba Orban and Dana Smith and Eleanor Taylor and Waldman, {Adam D.} and Robbins, {Trevor W.} and Deakin, {J. F. William} and Nutt, {David J.} and Anne Lingford-Hughes and John Suckling",
note = "cited By 2",
year = "2017",
month = "1",
day = "1",
doi = "10.1177/0269881116668592",
language = "English",
volume = "31",
pages = "3--16",
journal = "Journal of Psychopharmacology",
issn = "0269-8811",
publisher = "SAGE Publications Ltd",
number = "1",

}

McGonigle, J, Murphy, A, Paterson, L, Reed, L, Nestor, LJ, Nash, J, Elliott, R, Ersche, KD, Flechais, R, Newbould, R, Orban, C, Smith, D, Taylor, E, Waldman, AD, Robbins, TW, Deakin, JFW, Nutt, DJ, Lingford-Hughes, A & Suckling, J 2017, 'The ICCAM platform study: An experimental medicine platform for evaluating new drugs for relapse prevention in addiction. Part B: fMRI description', Journal of Psychopharmacology, vol. 31, no. 1, pp. 3-16. https://doi.org/10.1177/0269881116668592

The ICCAM platform study : An experimental medicine platform for evaluating new drugs for relapse prevention in addiction. Part B: fMRI description. / McGonigle, John; Murphy, Anna; Paterson, Louise; Reed, Laurence; Nestor, Liam J.; Nash, Jonathan; Elliott, Rebecca; Ersche, Karen D.; Flechais, Remy; Newbould, Rexford; Orban, Csaba; Smith, Dana; Taylor, Eleanor; Waldman, Adam D.; Robbins, Trevor W.; Deakin, J. F. William; Nutt, David J.; Lingford-Hughes, Anne; Suckling, John.

In: Journal of Psychopharmacology, Vol. 31, No. 1, 01.01.2017, p. 3-16.

Research output: Contribution to journalArticle

TY - JOUR

T1 - The ICCAM platform study

T2 - Journal of Psychopharmacology

AU - McGonigle, John

AU - Murphy, Anna

AU - Paterson, Louise

AU - Reed, Laurence

AU - Nestor, Liam J.

AU - Nash, Jonathan

AU - Elliott, Rebecca

AU - Ersche, Karen D.

AU - Flechais, Remy

AU - Newbould, Rexford

AU - Orban, Csaba

AU - Smith, Dana

AU - Taylor, Eleanor

AU - Waldman, Adam D.

AU - Robbins, Trevor W.

AU - Deakin, J. F. William

AU - Nutt, David J.

AU - Lingford-Hughes, Anne

AU - Suckling, John

N1 - cited By 2

PY - 2017/1/1

Y1 - 2017/1/1

N2 - Objectives:We aimed to set up a robust multi-centre clinical fMRI and neuropsychological platform to investigate the neuropharmacology of brain processes relevant to addiction – reward, impulsivity and emotional reactivity. Here we provide an overview of the fMRI battery, carried out across three centres, characterizing neuronal response to the tasks, along with exploring inter-centre differences in healthy participants.Experimental design:Three fMRI tasks were used: monetary incentive delay to probe reward sensitivity, go/no-go to probe impulsivity and an evocative images task to probe emotional reactivity. A coordinate-based activation likelihood estimation (ALE) meta-analysis was carried out for the reward and impulsivity tasks to help establish region of interest (ROI) placement. A group of healthy participants was recruited from across three centres (total n=43) to investigate inter-centre differences.Principle observations:The pattern of response observed for each of the three tasks was consistent with previous studies using similar paradigms. At the whole brain level, significant differences were not observed between centres for any task.Conclusions:In developing this platform we successfully integrated neuroimaging data from three centres, adapted validated tasks and applied whole brain and ROI approaches to explore and demonstrate their consistency across centres.

AB - Objectives:We aimed to set up a robust multi-centre clinical fMRI and neuropsychological platform to investigate the neuropharmacology of brain processes relevant to addiction – reward, impulsivity and emotional reactivity. Here we provide an overview of the fMRI battery, carried out across three centres, characterizing neuronal response to the tasks, along with exploring inter-centre differences in healthy participants.Experimental design:Three fMRI tasks were used: monetary incentive delay to probe reward sensitivity, go/no-go to probe impulsivity and an evocative images task to probe emotional reactivity. A coordinate-based activation likelihood estimation (ALE) meta-analysis was carried out for the reward and impulsivity tasks to help establish region of interest (ROI) placement. A group of healthy participants was recruited from across three centres (total n=43) to investigate inter-centre differences.Principle observations:The pattern of response observed for each of the three tasks was consistent with previous studies using similar paradigms. At the whole brain level, significant differences were not observed between centres for any task.Conclusions:In developing this platform we successfully integrated neuroimaging data from three centres, adapted validated tasks and applied whole brain and ROI approaches to explore and demonstrate their consistency across centres.

KW - brain

KW - human

KW - magnetic resonance imaging

KW - substance-related disorders

UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85009508785&doi=10.1177%2f0269881116668592&partnerID=40&md5=2b227fb618ec29f832f75cad05efaf8b

U2 - 10.1177/0269881116668592

DO - 10.1177/0269881116668592

M3 - Article

VL - 31

SP - 3

EP - 16

JO - Journal of Psychopharmacology

JF - Journal of Psychopharmacology

SN - 0269-8811

IS - 1

ER -